How China is Rewriting the Rules of AI Healthcare with Dr. Ruby Wang

China’s biotech and healthcare sectors are evolving at extraordinary speed — from AI-powered “doctor avatars” and digital health super apps to a wave of Chinese drug innovation reshaping the global pharmaceutical industry.In this episode, I speak with physician and healthcare strategist Dr. Ruby Wang about the latest trends in China's AI + healthcare innovation.We discuss:Why Western pharma companies are rushing to license Chinese drugsChina’s rise as a global biotech powerhouseAI doctors, digital hospitals, and health super appsThe role of Alibaba, Ant Group, and DeepSeek in healthcareWhy China’s healthcare digitization is moving faster than the WestThe future of AI in medicine and diagnosticsChinese medical devices, robotics, and healthcare hardwareHow Chinese regulators accelerated biotech innovationWhether healthcare can become China’s next major global export industryThe challenges China still faces in healthcare access and inequalityRuby Wang is a UK-trained physician, founder of China Health Pulse, and author of the upcoming book China Cure, which explores the global impact of China’s biotech and AI healthcare advances.Links:China Health Pulse newsletter and podcast: https://www.chinahealthpulse.com/For transcripts and more, check out the ⁠High Capacity newsletter⁠: https://www.highcapacity.org/More about the host, Kyle Chan: https://www.kyleichan.com/